ACUT
Price
$0.89
Change
-$0.01 (-1.11%)
Updated
Jun 24 closing price
Capitalization
14.24M
PHGE
Price
$0.44
Change
-$0.01 (-2.22%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
11.78M
Interact to see
Advertisement

ACUT vs PHGE

Header iconACUT vs PHGE Comparison
Open Charts ACUT vs PHGEBanner chart's image
Accustem Sciences
Price$0.89
Change-$0.01 (-1.11%)
Volume$1.08K
Capitalization14.24M
BiomX
Price$0.44
Change-$0.01 (-2.22%)
Volume$1.7K
Capitalization11.78M
ACUT vs PHGE Comparison Chart in %
Loading...
PHGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACUT vs. PHGE commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACUT is a Hold and PHGE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (ACUT: $0.89 vs. PHGE: $0.45)
Brand notoriety: ACUT and PHGE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACUT: 32% vs. PHGE: 61%
Market capitalization -- ACUT: $14.24M vs. PHGE: $11.78M
ACUT [@Biotechnology] is valued at $14.24M. PHGE’s [@Biotechnology] market capitalization is $11.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACUT’s FA Score shows that 1 FA rating(s) are green whilePHGE’s FA Score has 1 green FA rating(s).

  • ACUT’s FA Score: 1 green, 4 red.
  • PHGE’s FA Score: 1 green, 4 red.
According to our system of comparison, ACUT is a better buy in the long-term than PHGE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHGE’s TA Score shows that 5 TA indicator(s) are bullish.

  • PHGE’s TA Score: 5 bullish, 3 bearish.

Price Growth

ACUT (@Biotechnology) experienced а -15.62% price change this week, while PHGE (@Biotechnology) price change was -3.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.46%. For the same industry, the average monthly price growth was +36.24%, and the average quarterly price growth was +15.15%.

Reported Earning Dates

PHGE is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+8.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACUT($14.2M) has a higher market cap than PHGE($11.8M). ACUT YTD gains are higher at: 97.768 vs. PHGE (-38.365). ACUT has higher annual earnings (EBITDA): -1.42M vs. PHGE (-6.21M). PHGE has more cash in the bank: 20.1M vs. ACUT (36.4K). ACUT has less debt than PHGE: ACUT (57.6K) vs PHGE (9.29M). ACUT (0) and PHGE (0) have equivalent revenues.
ACUTPHGEACUT / PHGE
Capitalization14.2M11.8M120%
EBITDA-1.42M-6.21M23%
Gain YTD97.768-38.365-255%
P/E RatioN/A0.02-
Revenue00-
Total Cash36.4K20.1M0%
Total Debt57.6K9.29M1%
FUNDAMENTALS RATINGS
PHGE: Fundamental Ratings
PHGE
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
74
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PHGE
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
PHGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ESOA9.530.29
+3.14%
Energy Services of America Corp
WSO434.4310.83
+2.56%
Watsco
ADNT19.710.36
+1.86%
Adient plc
NN15.080.14
+0.94%
NextNav
AEI0.94-0.04
-4.07%
Alset

ACUT and

Correlation & Price change

A.I.dvisor tells us that ACUT and KMSTF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACUT and KMSTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACUT
1D Price
Change %
ACUT100%
N/A
KMSTF - ACUT
28%
Poorly correlated
N/A
MOLN - ACUT
21%
Poorly correlated
-3.00%
PHGE - ACUT
20%
Poorly correlated
-6.05%
TELIF - ACUT
11%
Poorly correlated
+34.98%
BLTE - ACUT
11%
Poorly correlated
-1.96%
More

PHGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHGE has been loosely correlated with APM. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if PHGE jumps, then APM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHGE
1D Price
Change %
PHGE100%
-6.05%
APM - PHGE
60%
Loosely correlated
-1.07%
HOFBF - PHGE
35%
Loosely correlated
N/A
NRIX - PHGE
27%
Poorly correlated
+1.89%
AVTX - PHGE
26%
Poorly correlated
-0.63%
CABA - PHGE
23%
Poorly correlated
-3.95%
More